Cardiology

Experimental vaccine may reduce post-stroke blood clot risk

A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to ...

Cardiology

Experimental vaccine may reduce post-stroke blood clot risk

A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to ...

Oncology & Cancer

Researchers testing new brain cancer vaccine

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma—an aggressive form of brain cancer with very few current ...

Diseases, Conditions, Syndromes

NIH begins clinical trial of live, attenuated Zika vaccine

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ...

page 7 from 18